Order Code CORT Cortisol, Serum
Additional Codes
Epic Order ID LAB4082
Previous Epic Order ID LAB2185
Reporting Name
Cortisol, SUseful For
Discrimination between primary and secondary adrenal insufficiency
Differential diagnosis of Cushing syndrome
This test is not recommended for evaluating response to metyrapone.
Performing Laboratory
![](http://d3b6ik53zt4tlx.cloudfront.net/assets/performed-by-mcl.gif)
Specimen Type
SerumOrdering Guidance
The preferred screening test for Cushing syndrome measures 24-hour urinary free cortisol. Order CORTU / Cortisol, Free, 24 Hour, Urine.
For confirming the presence of synthetic steroids, order SGSS / Synthetic Glucocorticoid Screen, Serum.
For patients taking exogenous glucocorticoids, order CORTU / Cortisol, Free, 24 Hour, Urine.
For evaluating response to metyrapone, order DCORT / 11-Deoxycortisol, Serum.
For evaluation of congenital adrenal hyperplasia, the following tests provide better, accurate, and specific determination of the enzyme deficiency:
-DCORT / 11-Deoxycortisol, Serum
-OHPG / 17-Hydroxyprogesterone, Serum
-DHEA_ / Dehydroepiandrosterone (DHEA), Serum
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.6 mL
Collection Instructions:
1. Morning (8 a.m.) and afternoon (4 p.m.) specimens are preferred.
2. Serum gel tubes should be centrifuged within 2 hours of collection.
3. Red-top tubes should be centrifuged and the serum aliquoted into a plastic vial within 2 hours of collection.
Additional Information:
1. Include time of collection.
2. If multiple specimens are collected, send separate order for each specimen.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 90 days | ||
Ambient | 7 days |
Reference Values
0 -<3 months: 1.1-19 mcg/dL
3 months-<12 months: 2.6-23 mcg/dL
12 months-<13 years: 2.2-13 mcg/dL
13 years-<16 years: 3.0-17 mcg/dL
16 years -<18 years: 3.8-19 mcg/dL
≥18 years:
a.m.: 7-25 mcg/dL
p.m.: 2-14 mcg/dL
For SI unit Reference Values, see https://www.mayocliniclabs.com/order-tests/si-unit-conversion.html
Day(s) Performed
Monday through Saturday
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82533
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CORT | Cortisol, S | 87429-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CORTP | Cortisol, S | 83088-5 |
CAM | AM Result | 9813-7 |
CPM | PM Result | 9812-9 |
Clinical Information
Cortisol, the main glucocorticoid (representing 75%-90% of the plasma corticoids) plays a central role in glucose metabolism and in the body's response to stress.
Cortisol levels are regulated by adrenocorticotropic hormone (ACTH), which is synthesized by the pituitary gland in response to corticotropin-releasing hormone (CRH). CRH is released in a cyclic fashion by the hypothalamus, resulting in diurnal peaks (6 a.m.-8 a.m.) and troughs (11 p.m.) in plasma ACTH and cortisol levels.
The majority of cortisol circulates bound to cortisol-binding globulin (CBG-transcortin) and albumin. Normally, less than 5% of circulating cortisol is free (unbound). The free cortisol is the physiologically active form and is filterable by the renal glomerulus.
Although hypercortisolism is uncommon, the signs and symptoms are common (eg, obesity, high blood pressure, increased blood glucose concentration). The most common cause of increased plasma cortisol levels in women is a high circulating concentration of estrogen (eg, estrogen therapy, pregnancy) resulting in increased concentration of cortisol-binding globulin.
Spontaneous Cushing syndrome results from overproduction of glucocorticoids as a result of either primary adrenal disease (adenoma, carcinoma, or nodular hyperplasia) or an excess of ACTH (from a pituitary tumor or an ectopic source). ACTH-dependent Cushing syndrome due to a pituitary corticotroph adenoma is the most frequently diagnosed subtype; most commonly seen in women in the third through fifth decades of life. The onset is insidious and usually occurs 2 to 5 years before a clinical diagnosis is made.
Causes of hypocortisolism are:
-Addison disease-primary adrenal insufficiency
-Secondary adrenal insufficiency:
--Pituitary insufficiency
--Hypothalamic insufficiency
-Congenital adrenal hyperplasia-defects in enzymes involved in cortisol synthesis
Clinical Reference
1. Findling JW, Raff H. Diagnosis and differential diagnosis of cushing's syndrome. Endocrinol Metab Clin North Am. 2001;30(3):729-747
2. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289-294
3. Rifai N, Horvath AR, Wittwer CT. eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed. Elsevier; 2018
4. Javorsky B, Carroll T, Algeciras-Schimnich A, Singh R, Colon-Franco J, Findling J: SAT-390 new cortisol threshold for diagnosis of adrenal insufficiency after cosyntropin stimulation testing using the Elecsys cortisol II, access cortisol, and LC-MS/MS assays. J Endocr Soc. 2019;3(Suppl 1):SAT-390. doi: 10.1210/js.2019-SAT-390
Report Available
1 to 3 daysReject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | OK |
Method Name
Immunoenzymatic Assay